HomeNAUT • NASDAQ
add
Nautilus Biotechnology Inc
Previous close
$2.86
Day range
$2.86 - $2.94
Year range
$2.27 - $4.65
Market cap
362.02M USD
Avg Volume
64.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 21.61M | 19.64% |
Net income | -18.73M | -25.16% |
Net profit margin | — | — |
Earnings per share | -0.15 | -25.00% |
EBITDA | -21.09M | -19.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 181.37M | 8.38% |
Total assets | 288.65M | -16.55% |
Total liabilities | 39.16M | -7.14% |
Total equity | 249.49M | — |
Shares outstanding | 125.27M | — |
Price to book | 1.44 | — |
Return on assets | -18.18% | — |
Return on capital | -18.53% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -18.73M | -25.16% |
Cash from operations | -16.27M | -29.88% |
Cash from investing | 22.35M | 265.64% |
Cash from financing | 245.00K | 24,400.00% |
Net change in cash | 6.33M | 124.34% |
Free cash flow | -9.80M | -18.28% |
About
Founded
2016
Headquarters
Website
Employees
163